| Dr Anna B Kosturek, MD | |
|
130 W North St, New Castle, PA 16101-3906 | |
| (724) 658-3578 | |
| (724) 656-1325 |
| Full Name | Dr Anna B Kosturek |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 45 Years |
| Location | 130 W North St, New Castle, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811159510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD418102 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Life Center Corporation | 9335042514 | 21 |
News Archive
Research published today in the open access journal BMC Pediatrics suggests that very preterm babies, born between 28 and 31 weeks, could benefit from skin-to-skin cuddling with their mother before and during painful procedures such as a heel lance.
In the 1950s, thalidomide (Contergan) was prescribed as a sedative drug to pregnant women, resulting in a great number of infants with serious malformations. Up to now, the reasons for these disastrous birth defects have remained unclear.
Genentech, a member of the Roche Group, today announced plans to invest more than $285 million for the expansion of its biologics manufacturing facilities in Vacaville and Oceanside, California.
Some food groups in the Mediterranean diet are more important than others in promoting health and longer life according to new research published on bmj.com.
Eisai Inc. today announced that it has submitted simultaneous regulatory applications for approval of eribulin mesylate (also known as E7389) for the treatment of locally advanced or metastatic breast cancer to agencies in Japan, the United States and the European Union (EU). Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai.
› Verified 3 days ago
| Entity Name | Mercy Life Center Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720075104 PECOS PAC ID: 9335042514 Enrollment ID: O20040128000504 |
News Archive
Research published today in the open access journal BMC Pediatrics suggests that very preterm babies, born between 28 and 31 weeks, could benefit from skin-to-skin cuddling with their mother before and during painful procedures such as a heel lance.
In the 1950s, thalidomide (Contergan) was prescribed as a sedative drug to pregnant women, resulting in a great number of infants with serious malformations. Up to now, the reasons for these disastrous birth defects have remained unclear.
Genentech, a member of the Roche Group, today announced plans to invest more than $285 million for the expansion of its biologics manufacturing facilities in Vacaville and Oceanside, California.
Some food groups in the Mediterranean diet are more important than others in promoting health and longer life according to new research published on bmj.com.
Eisai Inc. today announced that it has submitted simultaneous regulatory applications for approval of eribulin mesylate (also known as E7389) for the treatment of locally advanced or metastatic breast cancer to agencies in Japan, the United States and the European Union (EU). Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anna B Kosturek, MD 130 W North St, New Castle, PA 16101-3906 Ph: (724) 658-3578 | Dr Anna B Kosturek, MD 130 W North St, New Castle, PA 16101-3906 Ph: (724) 658-3578 |
News Archive
Research published today in the open access journal BMC Pediatrics suggests that very preterm babies, born between 28 and 31 weeks, could benefit from skin-to-skin cuddling with their mother before and during painful procedures such as a heel lance.
In the 1950s, thalidomide (Contergan) was prescribed as a sedative drug to pregnant women, resulting in a great number of infants with serious malformations. Up to now, the reasons for these disastrous birth defects have remained unclear.
Genentech, a member of the Roche Group, today announced plans to invest more than $285 million for the expansion of its biologics manufacturing facilities in Vacaville and Oceanside, California.
Some food groups in the Mediterranean diet are more important than others in promoting health and longer life according to new research published on bmj.com.
Eisai Inc. today announced that it has submitted simultaneous regulatory applications for approval of eribulin mesylate (also known as E7389) for the treatment of locally advanced or metastatic breast cancer to agencies in Japan, the United States and the European Union (EU). Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai.
› Verified 3 days ago
Dr. Mark Ayad Matta, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2616 Wilmington Rd, Suite A, New Castle, PA 16105 Phone: 724-652-2323 Fax: 724-654-3461 | |
Dr. William Randolph Richardson, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11 Shenango Rd, Ste 1, New Castle, PA 16105 Phone: 724-657-1881 Fax: 724-657-9178 | |
Dr. Rasim Somer Diler, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2703 W State St, New Castle, PA 16101 Phone: 724-657-3303 Fax: 724-657-3326 |